LONGEVERON
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. This is through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors. The Longeveron-grown Mesenchymal Stem Cell (LMSCs) product is manufactured in Longeveron’s cell processing facility located in Miami, Florida.
LONGEVERON
Industry:
Biotechnology Life Science Medical
Founded:
2014-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.longeveron.com
Total Employee:
11+
Status:
Active
Contact:
305.909.0840
Total Funding:
9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Sitelinks Search Box Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Alzheimer's Association
Alzheimer's Association investment in Grant - Longeveron
National Institutes of Health
National Institutes of Health investment in Grant - Longeveron
TEDCO
TEDCO investment in Grant - Longeveron
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-09 | Longeveron Announces CEO Transition - May 09, 2022 |
| 2022-04-05 | Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer |
Official Site Inspections
http://www.longeveron.com Semrush global rank: 6.6 M Semrush visits lastest month: 934
- Host name: cloudhost-4388385.us-midwest-2.nxcli.net
- IP address: 192.190.220.86
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Longeveron"
Longeveron - Cell-Based Therapies - Miami
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Through patient-focused, regenerative medicine, our research and …See details»
About Us - Longeveron
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-Bâ„¢, which is derived from culture-expanded medicinal signaling …See details»
Leadership - Longeveron
Kwan-Hong Chris Min joined Longeveron in 2022 leading the global clinical development and regulatory strategy for Longeveron’s investigational products. On April 1, 2023, he began …See details»
Longeveron Selects Clinical Research Organization for Phase 2 …
MIAMI, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for …See details»
Longeveron Selects Clinical Research Organization for Phase
Nov 5, 2021 · Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions.See details»
Longeveron - Crunchbase Company Profile & Funding
Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. Longeveron's primary investigational product, Lomecel-Bâ„¢, is an allogeneic medicinal signaling cell (MSC) therapy …See details»
Longeveron Announces First Quarter 2024 Financial …
MIAMI, May 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, …See details»
Investors - Longeveron
We believe that by using the same cells that promote tissue repair, organ maintenance, and immune system function, we can develop safe and effective therapies for some of the most …See details»
Longeveron, LLC - MSCRF
Nov 1, 2024 · Longeveron LLC is a leading global regenerative medicine company developing innovative stem cell treatments that target chronic and life-threatening diseases. Through its …See details»
News - Alzheimer's Association
CHICAGO, July 23, 2019 —The Alzheimer’s Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, …See details»
Mission and Values - Longeveron
We value the autonomy of every person and hold ourselves accountable to the improvement of health for all. We uphold the highest ethical standards for our research. We endeavor to bring …See details»
Longeveron Issues Letter to Shareholders Highlighting Corporate ...
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) - Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the …See details»
Longeveron Reports Year-End 2023 Results and Provides …
MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for …See details»
Longeveron LLC - VentureRadar
Website: http://longeveron.com/ Develops regenerative medicines targeting aging-related and life-threatening conditions, specializing in stem cell therapies to improve healthspan and address …See details»
Longeveron® Announces Third Quarter 2024 Financial Results and …
MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life …See details»
Longeveron® Announces Second Quarter 2024 Financial Results …
Aug 14, 2024 · Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is …See details»
Longeveron Inc. (LGVN) - Yahoo Finance Canada
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead...See details»
Longeveron Announces Closing of $5.2 Million Public Offering
Apr 11, 2024 · Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is …See details»
Longeveron Company Profile - Office Locations, Competitors, …
Oct 29, 2024 · Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. Its investigational product candidate (LMSC) is based on a …See details»
Longeveron Announces Board of Directors Planned Transitions
MIAMI, May 10, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life …See details»